Related Content
August 15, 2013 — The first implantation of Tyrx Inc.’s new AigisRx R Fully Resorbable Antibacterial Envelope has taken ...
August 15, 2013
May 16, 2013 — The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device ...
May 16, 2013
April 15, 2013 — Tyrx announced the first implantation of its new AigisRx R Fully Resorbable Antibacterial Envelope has ...
April 15, 2013April 8, 2013 — Tyrx Inc. has received a license from Health Canada to market its new AigisRx R Fully Resorbable ...
April 08, 2013
October 12, 2012 — TyRx Inc. said it received a license from Health Canada to market its AigisRx Antibacterial Envelope ...
October 12, 2012
August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid ...
August 03, 2012March 20, 2012 - TyRx Inc. announced the launch of its new patient education website, HeartDeviceInfection.com. It was ...
March 13, 2012October 29, 2010 – Site enrollment has been completed for the 50-site CITADEL and CENTURION clinical studies to evaluate ...
October 29, 2010
October 20, 2010 – New study results show that patients undergoing cardiac implantable electronic device (CIED) ...
October 20, 2010
April 14, 2010 – An antibacterial wrap for implanted pacemakers and defibrillators released this week is designed to ...
April 14, 2010